𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risk of Clinical Fractures After Gonadotropin-Releasing Hormone Agonist Therapy for Prostate Cancer

✍ Scribed by Smith, Matthew R.; Boyce, Simone Peart; Moyneur, Erick; Duh, Mei Sheng; Raut, Monika K.; Brandman, Jane

Book ID
122843934
Publisher
Lippincott Williams and Wilkins
Year
2006
Tongue
English
Weight
64 KB
Volume
175
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Metabolic changes during gonadotropin-re
Metabolic changes during gonadotropin-releasing hormone agonist therapy for prostate cancer : Differences from the classic metabolic syndrome
✍ Matthew R. Smith; Hang Lee; Francis McGovern; Mary Anne Fallon; Melissa Goode; A πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

## Abstract ## BACKGROUND. In men with prostate cancer, gonadotropin‐releasing hormone (GnRH) agonists increase fat mass, decrease insulin sensitivity, and increase triglycerides, features that are shared with metabolic syndrome. To the authors' knowledge, however, less is known regarding the effe